OMNI ORTHOPEADICS produces a range of hip and knee implants for the growing total joint replacement market. OMNI’s product offering is centered on innovative implant and instrumentation design and the latest in navigation robotics technology. The business has a significant and growing surgeon base in the United States and has expanded into Europe.

Locations: New Zealand (Christchurch), United States (Taunton, Santa Clara), France (Grenoble).
More information:
Investment status: Past (private equity - acquired by Corin (LSE: CRG and backed by Permira)).